Therapy Comparison for Early-Onset MS After Age 50
Escalation vs. Induction Therapy Strategy in Patients With Early-Onset MS After Age 50
- Age
- 50 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 830 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Other
This trial is looking for patients with multiple sclerosis who started showing symptoms after age 50. Participants will be part of a study comparing different treatment approaches to see which may better manage the condition.
You may be able to join if
- I have been diagnosed with relapsing-remitting MS after age 50.
- I started my first treatment for MS within 2 years of my first symptoms.
- I am using moderately effective MS treatments.
- I am using highly effective MS treatments.
You may not be able to join if
- I have early progressive MS.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe objective of this study is to evaluate the risk of inflammatory disease activity by retrospectively comparing two therapeutic strategies (escalation group and induction group). The investigators also aim to identify factors associated with inflammatory relapse and treatment-related complications.
Loading trial locations…